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PATIENTS AND
METHODS
Prospective study was performed between November 2011 and October 2012 to standardize
2-port LRC, lymph node dissection, and urinary diversion. Twenty patients were intervened
(8 ileal conduit, 12 neobladder) and followed up for >1 yr. Median follow-up was 75.5 weeks
(interquartile range, 65.2-86 weeks). A reusable system placed through the umbilicus and
laparoscopic curved instruments with double rotation, plus one 10-mm extra port placed in the
right iliac fossa were used. Neobladder or conduit was performed extracorporeally. Preoperative,
perioperative, and pathologic outcomes and long-term security data are presented.RESULTS Median age was 69.5 years; body mass index, 27.4 kg/m2; operative time, 335 minutes; estimated
blood loss, 337 mL; hospital stay, 9 days; intraoperative transfusion rate, 10%; and visual analog
pain score, 3 at day 3. Surgical margin was positive in a case (5%); 3 (15%) were pT0, 2 (10%)
pT1, 5 (25%) pT2, 6 (30%) pT3a, 3 (15%) pT3b, and 1 (5%) pT4. The number of nodes
removed was 18.5 (interquartile range, 16-29.2), 4 (20%) positive. Complications were major in
2 (10%; fecal peritonitis and urinary sepsis) and minor in 4 (20%; ileus and 3 postoperative
transfusion) cases. No case required additional analgesia. Incision was totally hidden in the
umbilicus. Continence rate in neobladders was 91.7% at daytime and 75% at nighttime. Study
limitation was the absence of a comparative cohort.CONCLUSION Umbilical 2-port LRC is feasible with good oncologic and functional outcomes, low postoperative
pain, and absence of abdominal wall complications. Difﬁculties have slowed laparoendoscopic
single-site radical cystectomy, but umbilical 2-port LRC is a very acceptable alternative for
minimally invasive surgery of muscle-invasive bladder cancer. UROLOGY 84: 1088e1093, 2014.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).aparoendoscopic single-site surgery (LESS) has
become widely applicable in different urologicLsettings and for many different procedures.1 New
technical developments that include the application of
robots and precise manual systems are contributing to
further development of this new ﬁeld in pelvic surgery.2,3
However, LESS application for bladder cancer surgery
remains one of the least used indications, possibly for the
drawback that constitutes performance of such time-
consuming and complex procedures like radical cys-
tectomy, lymph node dissection, and urinary diversion.rs declare that they have no relevant ﬁnancial interests.
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reconstructive surgery that must complete the extirpative
procedure.4
Urothelial bladder cancer is a very common malig-
nancy in the elderly population of both the United States
and Europe, and Spain is one of the territories of Western
Europe with the highest incidence of bladder cancer
among men and one of the lowest among women.5
Complete removal of the bladder within the standard
limits and thorough extirpation of the pelvic lymph nodes
remains the preferred therapeutic option for muscle-
invasive disease in our environment, also in the elderly
population. Both laparoscopic radical cystectomy (LRC)
and robot-assisted LRC appear feasible alternatives6,7 and
have been recently promoted as they deﬁnitely allow an
earlier return to normal bowel function, shortened hos-
pital stay,8,9 and equivalent outcomes to open radical
cystectomy.10,11 However, it must be recognized that the




The difﬁculty for internal construction of laparoscopic
neobladders may at least in part explain the reluctance of
some academic centers to consider laparoscopic and/or
robotic surgery the gold standard of care in this type of
patients.12-14 Since its original description in 2009,15 lap-
aroendoscopic radical cystectomy through different single-
port systems has been reported worldwide in <30 cases,
using either robotic, manual, or hand-made platforms.1,15-21
We have systematized a new technique of LRC and
urinary diversion using 2 ports (2-port LRC). A reusable,
tri-channel, single-port platform is placed in the umbili-
cus. It incorporates bended instruments with a new sys-
tem that allows precise movements, recovering of
triangulation, and additional avoidance of both internal
and external clashing.3,21-23 A 10-mm lateral port placed
on the right iliac fossa facilitates intracorporeal suture for
orthotopic bladder substitution and external conduction
of drainage and ureteral catheters. Our initial experience
with this technique and a minimum of 1-yr follow-up for
each patient is presented.
PATIENTS AND METHODS
Study Population
From November 2011 to October 2012, consecutive patients
with diagnosis of nonmetastatic muscle-invasive bladder cancer
considered as candidates for radical surgery received informed
consent for 2-port LRC. All patients accepted the procedure
and admitted extra ports placed or incisions performed, if
necessary. Previous abdominal surgery was not considered a
contraindication. However, patients with morbid obesity, pelvic
radiation, and operations for colonic carcinoma were excluded.
No patient received induction chemotherapy either. Data were
prospectively entered into an institutional review board-
eapproved database that included demographics, tumor char-
acteristics, operative parameters, outcomes, and follow-up.
Estimated blood loss; differential hemoglobin, calculated as
postoperative day 2 minus preoperative day 14; operative time;
conversion to standard laparoscopy; intraoperative and post-
operative complications, according to the Clavien-Dindo clas-
siﬁcation24; transfusion rate; hospital length of stay; visual
analog pain score at day 3; and analgesic requirements at
discharge were considered the primary outcomes of the study.
In the initial 36 hours, all patients received epidural perfusion
of bupivacaine (0.125%) and fentanyl (2 mcg/mL) plus an
additional bolus of 3 mL on PCA, if needed (maximum 3 bolus/
h). Continuous intravenous metamizole sodium was used for the
next 36 hours, later substituted by oral or intravenous narcotics as
required. Slow liquid intake started on day 2 and food intake on
day 5; surgical drainage was removed on day 4, ureteral stents on
day 10, and Foley catheter on day 14 under ﬂuoroscopic control.
Patients were discharged in the absence of complications after
stool passage and with stable hemoglobin. Patients with positive
nodes or macroscopic fat inﬁltration received adjuvant systemic
chemotherapy. Cosmetic result according to a visual analog
wound satisfaction scale from 0 to 10 was investigated at the ﬁrst
month. Later, all subjects were followed up in an outpatient
clinic every 3 months. Minimal follow-up exceeded 1 year.
Patient Preparation
All patients underwent staging procedures to rule out metastatic
or unresectable nodal disease. Bowel was prepared with oralUROLOGY 84 (5), 2014administration of 1.5-L electrolyte lavage solution the afternoon
before the operation. A single-shot antibiotic prophylaxis with
cefazolin 1.5 g and metronidazole 0.5 g was administered
intravenously before the operation. Bilateral leg compression
stockings and low-dose low-molecular-weight heparin were used
for thrombosis prophylaxis.
Surgical Technique
A surgical video showing all the steps is included as
Supplementary Material. The patient was placed in the Tren-
delenburg position. KeyPort (Richard Wolf GmbH, Knittlingen,
Germany) is a reusable rigid trocar, sized 2.5 cm at the tip and
3.5 cm at the base, inserted in a screw-driven fashion, and ﬁtted
to a 2.5-cm umbilical opening without the need for external or
internal ﬁxation. The inner element was removed, and the soft
multichannel cover with 3 openings (5, 10, and 15 mm,
respectively) was closed to insert curved instruments composed
of inner sheath, outer element, and handle. These instruments
incorporated a new DuoRotate system (Richard Wolf GmbH)
that allowed precise movements of the tips after alignment of
the arms. A 5.3 mm wide, 50 cm long, 0 lens laparoscope and 2
operative curved instruments (atraumatic prehension forceps
and Metzenbaum scissors) were used in turns with a ForceTriad
(5 or 10 mm, if desired; Covidien), Hem-o-lok (Teleﬂex) clip
applier, and ENDOPOUCH RETRIEVER (Johnson &
Johnson).
The technique essentially duplicated that of radical open
cystectomy and included a thorough pelvic lymphadenectomy.
Umbilical placement of the system hid the surgical scar in the
navel and gave the ﬁnal appearance of a scar-free surgery. The
ﬁrst surgeon placed over the head of the patient and, if right
handed, used the forceps graspers with the left hand (appeared
on the right side of the screen) and scissors with the right hand
(visible on the left; Fig. 1A). The second surgeon held the 10-
mm additional port placed in the right iliac fossa with the right
hand and the lens with the left one. This access was ideal to
insert the suction irrigation system (Richard Wolf GmbH),
perform the anastomosis using a straight needle holder and
extract the drainage and ureteral stents distant from the umbi-
licus preventing hematoma formation or infection. This port
also facilitated proper working angle and avoided clashing of the
laparoscope with the instruments.
Surgery began with the opening of the parietal peritoneum,
ureteral identiﬁcation, opening of the pouch of Douglas,
dissection of the seminal case, and ligation of the vas deferens
and superior vesical pedicle with Hem-o-lok. Dissection of the
distal portion of the ureter was completed before ligation with
Hem-o-lok and section. Hemostasis of seminal pedicles was
followed with 10-mm LigaSure (Covidien), the space of Retzius
to the prostatic apex developed, the Santorini plexus was
controlled, and the urethra was sectioned. Bilateral obturator
and pelvic common iliac lymph node dissection up to the aortic
bifurcation was performed and the specimen was removed. The
intestinal loop 15 cm from the ileocecal valve was marked with
a reference suture and Hem-o-lok to help at the time of selec-
tion of the intestinal segment. The cystectomy specimen was
bagged, the KeyPort screwed out, and the purse extracted
through the umbilical opening in the linea alba.
With the help of a grasping forceps placed through the
10-mm port, the intestinal suture and ureters were extracted out
through the umbilical incision, which slightly extended when a
disposable disc was placed to facilitate exposure of the bowel
outside the navel. Ileoileal anastomosis was performed1089
Figure 2. (A) Postoperative occult scar in the umbilicus 7 weeks after surgery in a patient with orthotopic neobladder. (B) Pelvic
computed tomography scan of the same patient with total continence recovered at 6 months. (Color version available online.)
Figure 1. (A) Two-port laparoscopic radical cystectomy using umbilical KeyPort with a 5.3-mm lens and 2 operative curved
inserts, plus an additional 10-mm port in right iliac fossa. (B) Completed neobladder construction outside the umbilicus
before reintroduction into the abdominal cavity. (Color version available online.)extracorporeally with mechanical sutures. If a conduit was
elected, a 15-cm intestinal segment of ileum was isolated, and
separate Bricker anastomosis to the distal end of spatulated
ureters and cutaneous ileostomy were performed. If a neobladder
was preferred, a 45- to 50-cm intestinal segment was detubu-
larized to construct Studer reservoir with a straight needle
absorbable suture. The ureters were anastomosed to the afferent
loop, and a distal oriﬁce was left to face the urethral end before
the neobladder was reintroduced into the pelvic cavity
(Fig. 1B). Intestinal workout was performed fast to avoid
mesenteric edema.
The KeyPort system was reintroduced, and pneumo-
peritoneum was restored to perform the urethral anastomosis
with 2 barbed GLYCOMER V-Loc 90 2-0 (Covidien) hemi-
sutures around a 20F Foley catheter that meet at the
12-o’clock position. Urethropexy with suture ﬁxation to the
pubic bone was developed by traction with Hem-o-lok place-
ment and watertightness tested with instillation of 100-200 mL
of saline into the neobladder. A BLAKE drain (Johnson &
Johnson) was inserted into the pelvis though the umbilical port
and extracted out together with both ureteral stents through the
10-mm extra port. At the end of the procedure, the ports were
removed and the wounds closed with 3-0 VICRYL RAPIDE
(Johnson & Johnson). Some weeks later, the umbilical scar
appeared invisible (Fig. 2).
Statistical Analysis
Descriptive analyses were performed regarding patient charac-
teristics, perioperative results, surgical complications, and short-
term measurements of convalescence. Statistics are shown in the
cross tables, with medians and range given for continuous data1090and proportions for categorical data. Differences between groups
according to the type of urinary diversion were evaluated using
the t test for variables normally distributed and the Mann-
Whitney U test for variables that do not follow a normal dis-
tribution, according to the Kolmogorov-Smirnov and the
Shapiro-Wilk tests.
RESULTS
Orthotopic bladder substitution was performed in 12
(60%) patients and ileal conduit in 8 (40%). Male-to-
female distribution was 5.7:1. Median follow-up was
75.5 (interquartile range [IQR], 65.2-86, range 62-97) wk
[75.5 (IQR 65.5-86.7, range 62-97) for neobladder and 72
(IQR 64.5-86, range, 62-87) for conduit; P ¼ .82]. Me-
dian age, body mass index, Charlson comorbidity index,
American Society of Anesthesiologists score, and histo-
logic characteristics of the tumors are described in
Table 1. The median overall number of nodes removed
was 18.5 (IQR, 16-29.2, range 10-54). Surgical margins in
the cystectomy specimen were negative in all but 1 pa-
tient (focal positive margin lateral to the left ureter,
pT3aN2), who is alive without recurrence at 67 weeks
after the surgery. Pathologic results regarding pT and pN
categories, incidental prostate cancer, and associated
carcinoma in situ are detailed in Table 1. Differences
regarding demographic, clinical, and pathologic data
among the type of urinary diversion are shown. Patients
receiving ileal conduit were older than those treated with
orthotopic reservoir (P ¼ .03). Neobladder was preferredUROLOGY 84 (5), 2014
Table 1. Clinical and pathologic data of the patients
Characteristics Total (N ¼ 20) Ileal Conduit (N ¼ 8) Neobladder (N ¼ 12) P Value
Age, y (median IQR) 69.5 (63.2-77.7) 74.5 (70-82.2) 66 (61.5-75) .03
Male, n (%) 17 (85) 5 (62.5) 12 (100) .12
BMI, kg/m2 (median IQR) 27.4 (25.5-29.2) 27.7 (23.2-31.8) 27.3 (25.5-28.5) .68
Charlson comorbidity index (median IQR) 3 (2-4) 3 (2.2-5.7) 3.5 (2-4) .36
ASA grade 3-4, n (%) 7 (35) 3 (37.5) 4 (33.3) 1
pT category, n (%) .32
pT0 3 (15) 1 (12.5) 2 (16.7)
pT1 2 (10) 0 2 (16.7)
pT2 5 (25) 2 (25) 3 (25)
pT3a 6 (30) 1 (12.5) 5 (41.7)
pT3b 3 (15) 3 (37.5) 0
pT4 1 (5) 1 (12.5) 0
pN category, n (%) 1
pN0 16 (80) 6 (75) 10 (83.3)
pN1 2 (10) 1 (37.5) 1 (8.3)
pN2 2 (10) 1 (12.5) 1 (8.3)
No. of nodes removed (median IQR) 18.5 (16-29.2) 17 (17-34.7) 23.5 (17-29.2) .24
Positive surgical margins, n (%) 1 (5) 0 1 (8.3) 1
Incidental prostate cancer, n (%) 5 (25) 2 (25) 3 (25) .57
Associated carcinoma in situ, n (%) 5 (25) 3 (37.5) 2 (16.7) .3
ASA, American Society of Anesthesiologists; BMI, body mass index; IQR, interquartile range.in men. Median duration of surgery and the proportion of
patients at lower pT categories were higher in patients
with neobladder, but these differences did not reach sta-
tistical signiﬁcance. Conversely, the proportion of pa-
tients receiving chemotherapy and the probability of
associated carcinoma “in situ” were lower in this group,
but also not reaching signiﬁcance (Table 1).
Operative time, perioperative blood loss and related
variables, and hospital stay are described in Table 2. No
case required additional ports or was converted to con-
ventional multiport laparoscopy or open surgery. Surgical
complications according to the Clavien-Dindo classiﬁ-
cation occurred in 30% of the patients, all of them
within the ﬁrst month. Complications were major in
10% (fecal peritonitis on postoperative day 5 due to
unnoticed rectal opening in a case and urinary sepsis,
readmission, and intensive care unit stay 7 weeks after
the surgery in another) and minor in 20% (paralytic ileus
in a patient and postoperative transfusion in 3, respec-
tively). The patient with fecal peritonitis needed total
parenteral nutrition and temporary colostomy, also per-
formed through single-port surgery with 2 accessory
ports.
The number and severity of postoperative complica-
tions were equivalent among patients receiving ileal
conduit or orthotopic reservoir. No case required anal-
gesia at discharge, but median visual analog pain scale at
day 3 was signiﬁcantly lower for neobladders (P ¼ .02).
No difference in median visual analog wound satisfaction
scale was detected between groups at the ﬁrst month
(Table 2). Of the 12 patients with neobladder, 11
(91.7%) and 9 (75%) recovered daytime and nocturnal
continences 1 year after the surgery. Sexual Health In-
ventory for Men score >21 was registered in 3 of 8
(37.5%) men who were potent before the surgery, despite
a nerve-sparing technique performed only in 2 patients.UROLOGY 84 (5), 2014Late complications (after 90 days) developed in 3
(15%) patients: pyelonephritis, pneumonia, and inguinal
hernia, respectively. No patient developed uretero-
intestinal stenosis. Also, no patient developed compli-
cations related to the abdominal wall (evisceration or
other parietal complications, eg, incisional hernia or
infection). In every case, the incision was totally hidden
in the umbilicus. Adjuvant chemotherapy was adminis-
tered in 6 (30%) cases. Two patients (11.8%) developed
metastasis without evidence of local progression at 47 and
61 weeks after the surgery, respectively.COMMENT
The technique of radical cystectomyhas evolved little until
the advent of LRC, which slowly progressed to become a
viable alternative to open surgery providing comparable
oncologic outcomes.10,25 The laparoscopic technique im-
plies a learning curve and morbidity largely resulting from
the urinary diversion procedure. However, performance of
an open-assisted laparoscopic approach with extracorpo-
real urinary diversion is more efﬁcient and safer than the
pure laparoscopic technique26 and allows rapid resumption
of oral ﬂuid and solid intake, shorter hospital stay, and less
intraoperative blood loss than that of the open surgery,
even in old patients.7,8 Besides, a good-quality pelvic
lymph node dissection associated to LRC is feasible.6
LESS has recently emerged with the intention to
enhance cosmetic beneﬁts and reduce morbidity of lapa-
roscopy, but its current place for such complex techniques
as radical cystectomy and urinary diversion is not well
established because the experience worldwide is very
limited and possibly because cosmesis is certainly not a
priority when performing this procedure. Only 2 short
series with a total of 8 patients described its pure perfor-
mance with disposable or homemade multichannel1091
Table 2. Operative and postoperative outcomes
Outcomes Total (N ¼ 20) Ileal Conduit (N ¼ 8) Neobladder (N ¼ 12) P Value
Operative time, min (median IQR) 335 (326-387) 330 (317-355) 365 (330-450) .12
Estimated blood loss, mL (median IQR) 337 (300-395) 340 (305-365) 322 (262-422) .64
Intraoperative transfusions, n (%) 2 (10) 1 (12.5) 1 (8.3) 1
Postoperative transfusions, n (%) 3 (15) 1 (12.5) 2 (16.7) 1
Hemoglobin difference, g/dL (median IQR) 2.6 (1.9-3.7) 2.6 (2.1-3.2) 2.6 (1.7-3.9) .86
Hospital stay, d (median IQR) 9 (8-11) 9.5 (8-11) 8.5 (7.2-10.7) .32
Total complications, n (%) 6 (30) 2 (25) 4 (33.3) 1
Clavien-Dindo grade, n (%) .71
1 0 0 0
2 4 (20) 1 (12.5) 3 (25)
3 1 (5) 1 (12.5) 0
4 1 (5) 0 1 (8.3)
5 0 0 0
VAPS at d 3, 0-10/10 (median IQR) 3 (2-4) 3.5 (3-4.7) 2 (2-3) .02
VAWSS at 1 mo, 0-10/10 (median IQR) 8 (7-9) 7.5 (7-8) 8 (7-9) .46
Adjuvant chemotherapy received, n (%) 6 (30) 4 (50) 2 (16.7) .3
VAPS, visual analog pain scale; VAWSS, visual analog wound satisfaction scale; other abbreviation as in Table 1.port.16,20 Because of the limitations inherent to this
approach, none of the patients received a neobladder.
Another group has described a hybrid LESS technique
successfully performing orthotopic neobladder with a
homemade multichannel port placed into a 4- to 5-cm
midline incision and another separate subumbilical port
for the laparoscope.18,19 Shortly, we have described the
ﬁrst hybrid LESS radical cystectomy with neobladder
performed through a reusable single-port platform and an
accessory port.4,21 In the meanwhile, another solution
investigated was the single-incision triangulated umbilical
surgery cystectomy with 3 ports that needs a C-shaped
incision, removal of a skin ﬂap, and transversal extension
to an 8-cm cutaneous wound.27 Finally, to overcome the
limitations of LESS and perform radical cystectomy safely,
we have systematized a 2-port technique using umbilical
reusable KeyPort with DuoRotate instruments and an
accessory 10-mm port placed in the iliac fossa used to
extract drainage and urinary diversion catheters, pre-
sented in this pilot feasibility study.
This original technique of umbilical KeyPort
radical cystectomy can be used for ileal conduit or
neobladder performance with a versatile, reusable,
cost-effective, single-port access, possibly cheaper
than homemade multichannel port based on dispos-
able elements.19,20 Also, umbilical placement of the
main port improves abdominal wall preservation and
allows excellent cosmetic results as the incision be-
comes invisible, and patient satisfaction with the
wound is high. Operating time is reasonable and
radical cystectomy achieved seems appropriate
regarding the number of excised nodes and the pos-
itive margin rate with limited complications, absence
of complications related to the abdominal wall, low
postoperative pain, and prompt recovery, thus ful-
ﬁlling all criteria of a minimally invasive secure sur-
gery. Election of appropriate materials such as a
barbed suture to ease anastomosis or Hem-o-lok and
ForceTriad for better hemostasis may be critical to
achieve optimum operative results.1092Our preliminary series suggest that the type of urinary
diversion is not necessarily associated with increased
complication rate.28 Besides, orthotopic bladder replace-
ment with the 2-port technique can be associated to
lower postoperative pain and complete recovery of self-
image. It can be discussed whether reducing the number
of incisions or performing the reconstruction intra-
corporeally could be least invasive, and also if the reduced
port itself really implies an advantage over the traditional
multiport approach; however, this technique we
described can be performed at a very reasonable time with
very high patient satisfaction and prompt recovery. The
main limitation of this study is the absence of a control
group that disables objective oncologic and functional
comparison.CONCLUSION
In summary, 2-port LRC using umbilical KeyPort is
feasible with low complication rate, good oncologic and
functional outcomes, low postoperative pain, and absence
of abdominal wall complications. This experience ex-
empliﬁes cancer control, adequate number of nodes
removed, and reasonable complications in line with other
reports in the literature7,8,10-13,25,26,29 that are not against
excellent cosmetic result. Besides, absence of visible
stigma of malignancy could be psychologically an
important item in these patients. Multicenter randomized
trials that deﬁnitely conﬁrm the advantages we expect
appear desirable. Also, this 2-port concept of laparoscopy
using a multichannel platform and a second accessory
access that was robotically conducted could also be
multiport as well, have potential application in the future
of robotic laparoendoscopic approach, and impose new
solutions for such a complex technique as LESS robotic
radical cystectomy.
Acknowledgments. The authors thank Mr. Jesus Arconada
(Grupo Taper, Madrid), Mr. Stefan Gille, Mr. Benjamin Seid-
enspinner, and Mr. Juergen Steinbeck (Richard Wolf GmbH,UROLOGY 84 (5), 2014
Knittlingen) for providing instrumentation and Mr Jose Domi-
nguez (Hospital Universitario de Getafe) for photographic
assistance.
References
1. Kaouk JH, Autorino R, Kim FJ, et al. Laparoendoscopic single-site
surgery in urology: worldwide multi-institutional analysis of 1076
cases. Eur Urol. 2011;60:998-1005.
2. White MA, Haber GP, Autorino R, et al. Robotic laparoendoscopic
single-site radical prostatectomy: technique and early outcomes. Eur
Urol. 2010;58:544-550.
3. Caceres F, Cabrera PM, Garcıa-Tello A, et al. Safety study of um-
bilical single-port laparoscopic radical prostatectomy with a new
DuoRotate System. Eur Urol. 2012;62:1143-1149.
4. Kaouk JH, Autorino R. Comment: laparoendoscopic radical cys-
tectomy with orthotopic ileal neobladder through umbilical single
port. Actas Urol Esp. 2012;36:562-563.
5. Guey LT, Garcıa-Closas M, Murta-Nascimento C, et al. Genetic
susceptibility to distinct bladder cancer subphenotypes. Eur Urol.
2010;57:283-292.
6. Nuñez-Mora C, Garcıa Mediero JM, Cabrera-Castillo PM, et al.
Feasibility of lymphadenectomy in laparoscopic radical cystectomy.
Urology. 2010;76:759-763.
7. Guillotreau J, Miocinovic R, Game X, et al. Outcomes of laparo-
scopic and robotic radical cystectomy in the elderly patients. Urol-
ogy. 2012;79:585-590.
8. Guillotreau J, Game X, Mouzin M, et al. Radical cystectomy for
bladder cancer: morbidity of laparoscopic versus open surgery.
J Urol. 2009;181:554-559.
9. Yu H, Hevelone ND, Lipsitz SR, et al. Comparative analysis of
outcomes and costs following open radical cystectomy versus robot-
assisted laparoscopic radical cystectomy: results from the US
Nationwide Inpatient Sample. Eur Urol. 2012;61:1239-1244.
10. Snow-Lisy DC, Campbell SC, Gill IS, et al. Robotic and laparo-
scopic radical cystectomy for bladder cancer: long-term oncologic
outcomes. Eur Urol. 2014;65:193-200.
11. Tyritzis SI, Hosseini A, Collins J, et al. Oncologic, functional, and
complications outcomes of robot-assisted radical cystectomy with
totally intracorporeal neobladder diversion. Eur Urol. 2013;64:734-741.
12. Jonsson MN, Adding LC, Hosseini A, et al. Robot-assisted radical
cystectomy with intracorporeal urinary diversion in patients with
transitional cell carcinoma of the bladder. Eur Urol. 2011;60:1066-
1073.
13. Haber GP, Crouzet S, Gill IS. Laparoscopic and robotic assisted
radical cystectomy for bladder cancer: a critical analysis. Eur Urol.
2008;54:54-64.
14. Hautmann RE. The oncologic results of laparoscopic radical cys-
tectomy are not (yet) equivalent to open cystectomy. Curr Opin
Urol. 2009;19:522-526.
15. White WM, Haber GP, Goel RK, et al. Single-port urological
surgery: single-center experience with the ﬁrst 100 cases. Urology.
2009;74:801-804.UROLOGY 84 (5), 201416. Kaouk JH, Goel RK, White MA, et al. Laparoendoscopic single-site
radical cystectomy and pelvic lymph node dissection: initial expe-
rience and 2-year follow-up. Urology. 2010;76:857-861.
17. Liu CX, Xu AB, Chen BS, et al. [Laparoendoscopic single-site
surgery radical cystectomy with orthotopic taenia myectomy sig-
moid neobladder: initial report] (in Chinese). Nan Fang Yi Ke Da
Xue Xue Bao. 2010;30:1385-1388.
18. Huang J, Lin TZ, Xu KW, et al. [Application of modiﬁed single
port laparoscopic radical cystoprostatectomy and orthotopic ileal
neobladder] (in Chinese). Zhonghua Yi Xue Za Zhi. 2010;90:
1542-1546.
19. Lin T, Huang J, Han J, et al. Hybrid laparoscopic endoscopic single-
site surgery for radical cystoprostatectomy and orthotopic ileal
neobladder: an initial experience of 12 cases. J Endourol. 2011;25:
57-63.
20. Ma LL, Bi H, Hou XF, et al. Laparoendoscopic single-site radical
cystectomy and urinary diversion: initial experience in China using
a homemade single-port device. J Endourol. 2012;26:355-359.
21. Angulo JC, Caceres F, Arance I, et al. Cistectomıa radical lapa-
roscopica con neovejiga ileal ortotopica a traves de puerto unico
umbilical. Actas Urol Esp. 2012;36:554-561.
22. Caceres F, Cabrera PM, Mateo E, et al. Puesta en marcha de un
programa de entrenamiento para laparoscopia urologica por puerto
unico. Actas Urol Esp. 2012;36:418-424.
23. Cabrera PM, Caceres F, Garcıa-Tello A, Angulo JC. Initial expe-
rience of umbilical laparoendoscopic single-site nephron-sparing
surgery with KeyPort and DuoRotate system. J Endourol. 2013;27:
566-572.
24. Dindo D, Demartines N, Clavien PA. Classiﬁcation of surgical
complications: a new proposal with evaluation in a cohort of 6336
patients and results of a survey. Ann Surg. 2004;240:205-213.
25. Haber GP, Gill IS. Laparoscopic radical cystectomy for cancer:
oncological outcomes at up to 5 years. BJU Int. 2007;100:137-142.
26. Gerullis H, Kuemmel C, Popken G. Laparoscopic cystectomy with
extracorporeal-assisted urinary diversion: experience with 34 pa-
tients. Eur Urol. 2007;51:193-198.
27. Horstmann M, Kugler M, Anastasiadis AG, et al. Laparoscopic
radical cystectomy: initial experience using the single-incision
triangulated umbilical surgery (SITUS) technique. World J Urol.
2012;30:619-624.
28. Gore JL, Yu HY, Setodji C, et al; and the Urologic Diseases in
America Project. Urinary diversion and morbidity after radical
cystectomy for bladder cancer. Cancer. 2010;116:331-339.
29. Aboumarzouk OM, Hughes O, Narahari K, et al. Safety and feasi-
bility of laparoscopic radical cystectomy for the treatment of bladder
cancer. J Endourol. 2013;27:1083-1095.
Supplementary data associated with this article
can be found, in the online version, at http://
dx.doi.org/10.1016/j.urology.2014.07.024.1093
